Format

Send to

Choose Destination
See comment in PubMed Commons below
Continuum (Minneap Minn). 2012 Feb;18(1):85-105. doi: 10.1212/01.CON.0000411569.72203.9d.

Immune-mediated neuropathies.

Author information

1
Stanford University, Department of Neurology, 300 Pasteur Drive, Room A342, Stanford, CA 94305, USA. ytso@stanford.edu

Abstract

PURPOSE OF REVIEW:

The immune-mediated neuropathies are an important group of treatable neuropathies that often lead to severe neurologic disability. This review guides clinicians in the recognition and treatment of these disorders.

RECENT FINDINGS:

Advances include new insights in classification and new treatment paradigms in many of these disorders.

SUMMARY:

Proper diagnosis and treatment require recognition of the characteristic clinical and laboratory findings and the use of appropriate electrophysiologic or pathologic examination. With proper treatment, partial or complete remission is possible, even in patients who are severely affected.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center